Healthy adults
Conditions
Interventions
None listed
Sponsors
KAGOME CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (PICOS) Participant: We will include healthy adults without illness (excluding pregnant women (including those planning to become pregnant) and lactating women). Intervention: Oral intake of test food containing SGS (regardless of the form and amount of intake) Comparison: Oral intake of test food without SGS, or no intervention Outcome measurement: Serum AST, ALT, and gamma-GTP Study design: Randomized controlled parallel trials (RCT-P), randomized controlled crossover trials (RCT-C), quasi-randomized controlled parallel trials (qRCT-P), quasi randomized controlled crossover trials (qRCT-C), non-randomized controlled parallel trials (nonRCT-P), non-randomized controlled crossover trials (nonRCT-C), and non-randomized controlled trials (Language) Eligibility is not restricted by language.
Exclusion criteria
Exclusion criteria: Exclude proceedings and unpublished studies which don't give us enough research details, and other gray documents that are difficult to verify.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyltransferase (gamma-GTP) | — |
Countries
Japan
Contacts
Public ContactShohei Satomi
KAGOME CO., LTD. Innovation Division
Outcome results
None listed